Ads
related to: BIOTECHNOLOGY VALUE FUND INC
Search results
Axxcess Wealth Management LLC Takes $30,000 Position in NautilusBiotechnology, Inc. (NASDAQ:NAUT)
ETF DAILY NEWS· 21 hours agoAxxcess Wealth Management LLC purchased a new stake in shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) during the 4th quarter, according ...
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks· 2 days agoMaking its debut on 06/23/2005, smart beta exchange traded fund Invesco Biotechnology & Genome ETF (PBE Quick QuotePBE - Free Report) provides investors ...
Natixis Advisors L.P. Sells 248 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
ETF DAILY NEWS· 23 hours agoNatixis Advisors L.P. cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the fourth quarter, according to the company in its...the ...
Benjamin F. Edwards & Company Inc. Buys New Stake in Medpace Holdings, Inc. (NASDAQ:MEDP)
ETF DAILY NEWS· 22 hours agoEdwards & Company Inc. purchased a new position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) in the fourth quarter, according to the ...
Sana Biotechnology Inc [SANA] stock for 236,300 USD was sold by Yang Patrick Y – Knox Daily
Knox Daily· 3 days agoFollowing the buying of shares at $5.50 each, the insider now holds 12,446,022 shares. Before that, ARCH Venture Fund X, L.P. had added 1,818,181 shares to its account. In ...
Chardan Capital Cuts Seres Therapeutics (NASDAQ:MCRB) Price Target to $6.00
ETF DAILY NEWS· 1 day agoSeres Therapeutics (NASDAQ:MCRB – Free Report) had its price objective decreased by Chardan Capital from $8.00 to $6.00 in a report published on Wednesday morning, Benzinga reports. Chardan ...
Mizuho Trims uniQure (NASDAQ:QURE) Target Price to $6.00
ETF DAILY NEWS· 20 hours agoSeveral other equities research analysts have also weighed in on QURE. Royal Bank of Canada reissued an outperform rating and set a $28.00 price objective on shares of uniQure in a research ...
Axxcess Wealth Management LLC Takes $352,000 Position in InvescoBiotechnology & Genome ETF...
ETF DAILY NEWS· 3 days agoAxxcess Wealth Management LLC acquired a new stake in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE – Free Report) during the fourth quarter, HoldingsChannel ...
Humacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic Advances
GuruFocus.com via Yahoo Finance· 1 day agoThe anticipated PDUFA date set for ...for Humacyte. In conclusion, Humacyte Inc's Q1 2024 performance reflects a strategic alignment of its developmental...
Equities Analysts Set Expectations for Enanta Pharmaceuticals, Inc.’s Q1 2025 Earnings (NASDAQ:ENTA)
ETF DAILY NEWS· 22 hours agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) – Research analysts at HC Wainwright issued their Q1...report issued to clients and investors on Tuesday, May 7th.